Machine learning reveals why cancer trials fall short in real-world patients

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research accuracy.